C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
08/2011
08/25/2011	WO2011103453A2 Vaccines for use in the prophylaxis and treatment of influenza virus disease
08/25/2011	WO2011103330A2 Novel phosphorylation of cardiac troponin i as a monitor for cardiac injury
08/25/2011	WO2011102999A2 Spink1 targeted therapy
08/25/2011	WO2011102556A1 Antibody against serotype a lipopolysaccharide of pseudomonas aeruginosa
08/25/2011	WO2011102555A1 Antibody against serotype g lipopolysaccharide of pseudomonas aeruginosa
08/25/2011	WO2011102554A1 Antibody against serotype b lipopolysaccharide of pseudomonas aeruginosa
08/25/2011	WO2011102553A1 Antibody against serotype i lipopolysaccharide of pseudomonas aeruginosa
08/25/2011	WO2011102552A1 Antibody against a band lipopolysaccharide of pseudomonas aeruginosa
08/25/2011	WO2011102551A1 Antibody against serotype e lipopolysaccharide of pseudomonas aeruginosa
08/25/2011	WO2011102483A1 HUMAN LAP TGF-β BINDING ANTIBODY
08/25/2011	WO2011101791A1 Anti-cd28 humanized antibodies
08/25/2011	WO2011101435A1 Activatable constructs
08/25/2011	WO2011101122A1 Anti-hpv e7 antibodies
08/25/2011	WO2011100786A1 Compositions and methods for targeting type 1 interferon producing cells
08/25/2011	WO2011080050A3 Ccl21 binding molecules
08/25/2011	US20110208673 Antibodies to lymphotoxin-alpha
08/25/2011	US20110207917 Sam-6 variants, target and methods of use
08/25/2011	US20110207767 Novel cc-1065 Analogs and Their Conjugates
08/25/2011	US20110207679 Methods of treatment using il-16 antagonist peptides
08/25/2011	US20110207677 Use of Cell-Permeable Peptide Inhibitors of the JNK Signal Transduction Pathway for the Treatment of Chronic or Non-Chronic Inflammatory Digestive Diseases
08/25/2011	US20110207669 Recombinant proteins having haemostatic activity and capable of inducing platelet aggregation
08/25/2011	US20110207667 Efficient expression of truncated human rnaset2 in e. coli
08/25/2011	US20110207212 T1r taste receptors and genes encoding same
08/25/2011	US20110207198 Compositions and methods for inhibiting mmset
08/25/2011	US20110207181 Isomaltulose synthases, polynucleotides encoding them and uses therefor
08/25/2011	US20110207171 Oligosaccharide modification and labeling of proteins
08/25/2011	US20110207152 Gelsolin binding agent compositions and uses of same
08/25/2011	US20110207133 Binding and functional assays that use the t1r3 receptor to screen for taste modulatory compounds
08/25/2011	US20110207127 Markers for detection of legionella pneumophila strains
08/25/2011	US20110207120 Wnt1 as a renal damage biomarker
08/25/2011	US20110206760 Angiopoietin derived peptides
08/25/2011	US20110206755 Methods and products for manipulating uncoupling protein expression
08/25/2011	US20110206718 Anti-fmd vaccine composition and preparation and use thereof
08/25/2011	US20110206704 Methods and compositions for modulating hepatocyte growth factor activator
08/25/2011	US20110206702 Compositions and methods for the diagnosis and treatment of tumor
08/25/2011	US20110206700 Anti-cd33 antibodies and methods for treatment of acute myeloid leukemia using the same
08/25/2011	US20110206698 Antagonist anti-il-7 receptor antibodies and methods
08/25/2011	US20110206697 Spink1 targeted therapy
08/25/2011	US20110206694 Prevention and treatment of gram negative, flagellated bacterial infections
08/25/2011	US20110206693 Lysine riboswitch and compositions and uses thereof
08/25/2011	US20110206692 Conformers of bacterial adhesins
08/25/2011	US20110206687 Isolation And Purification Of Anti-IL-13 Antibodies Using Protein A Affinity Chromatography
08/25/2011	US20110206686 Il-23 antibodies
08/25/2011	US20110206682 Monoclonal antibodies, synthetic and biotechnological derivatives thereof acting as ngf-antagonist molecules
08/25/2011	US20110206681 Binding molecules to the human ox40 receptor
08/25/2011	US20110206678 Antibodies Specific for Sclerostin and Methods for Increasing Bone Mineralization
08/25/2011	US20110206677 Antibodies specific for sclerostin and methods for increasing bone mineralization
08/25/2011	US20110206676 Compositions and methods related to staphylococcal bacterium proteins
08/25/2011	US20110206673 Polypeptides and polynucleotides for artemin and related ligands, and methods of use thereof
08/25/2011	US20110206672 Antigen-Binding Molecule And Uses Thereof
08/25/2011	US20110206671 Axon regeneration promoter
08/25/2011	US20110206668 Methods and compositions for modulating immunity
08/25/2011	US20110206664 Therapeutic agent for chronic arthritides diseases of childhood-related diseases
08/25/2011	US20110206663 Anti-Interferon-Alpha Antibodies
08/25/2011	US20110206660 Amino acid sequences directed against cxcr4 and other gpcrs and compounds comprising the same
08/25/2011	US20110206658 Compositions and methods for the treatment of tumor of hematopoietic origin
08/25/2011	US20110206657 Antibodies binding to an intracellular prl-1 or prl-3 polypeptide
08/25/2011	US20110206618 Fluorescent labeling material and flourescent labeling agent
08/25/2011	US20110206613 METHOD AND APPLICATION OF UNSYMMETRICALLY meso-SUBSTITUTED PORPHYRINS AND CHLORINS FOR PDT
08/25/2011	US20110206611 DNA Dendrimers as Thermal Ablation Devices
08/25/2011	CA2790290A1 Antibody against serotype g lipopolysaccharide of pseudomonas aeruginosa
08/25/2011	CA2790289A1 Antibody against serotype b lipopolysaccharide of pseudomonas aeruginosa
08/25/2011	CA2790276A1 Antibody against serotype a lipopolysaccharide of pseudomonas aeruginosa
08/25/2011	CA2790232A1 Antibody against serotype i lipopolysaccharide of pseudomonas aeruginosa
08/25/2011	CA2790228A1 Antibody against serotype e lipopolysaccharide of pseudomonas aeruginosa
08/25/2011	CA2790200A1 Monoclonal antibodies that inhibit the wnt signaling pathway and methods of production and use thereof
08/25/2011	CA2789810A1 Compositions and methods for targeting type 1 interferon producing cells
08/25/2011	CA2788544A1 Anti-cd28 humanized antibodies
08/25/2011	CA2788006A1 Anti-hpv e7 antibodies
08/24/2011	EP2360260A1 BASB006 polynucleotide(s) and polypeptides from Neisseria meningitis
08/24/2011	EP2360259A2 Promyostatin peptides and methods of using same
08/24/2011	EP2360257A2 Hepatitis B virus (HBV) variants
08/24/2011	EP2360256A1 Method for isolation of soluble polypeptides
08/24/2011	EP2360254A1 Assays for screening anti-pd-1 antibodies and uses thereof
08/24/2011	EP2360187A1 Antibodies against HER2 truncated variant CTF-611
08/24/2011	EP2360186A1 Anti-P-selectin antibodies
08/24/2011	EP2360185A2 Administration of agents for the treatment of inflammation
08/24/2011	EP2360184A2 Antibodies that bind human interleukin-18 and methods of making and using
08/24/2011	EP2360183A1 Antibody purification method
08/24/2011	EP2360182A1 Therapeutic targeting of escort proteins
08/24/2011	EP2360181A1 IL-21 variants
08/24/2011	EP2360177A1 Klebsiella antigens
08/24/2011	EP2360175A2 Norovirus and Sapovirus virus-like particles (VLPs)
08/24/2011	EP2360169A2 PSMA antibodies
08/24/2011	EP2360168A1 Flavivirus fusion inhibitors
08/24/2011	EP2359857A2 Compositions and methods for demonstrating secretory immune system regulation of steroid hormone responsive cancer cell growth
08/24/2011	EP2359855A2 Methods of administering anti-TNFalpha antibodies
08/24/2011	EP2359854A1 Pharmaceutical compositions and methods useful for modulating angiogenesis
08/24/2011	EP2359853A1 Pharmaceutical compositions and methods useful for modulating angiogenesis
08/24/2011	EP2359849A1 Combination therapy
08/24/2011	EP2359848A1 Peptide-based passive immunization therapy for treatment of atherosclerosis
08/24/2011	EP2359841A2 Survivin-derived peptides and use thereof
08/24/2011	EP2359685A1 Methods to engineer mammalian-type carbohydrate structures
08/24/2011	EP2358871A1 Erk1/2 phosphorylation site specific antibody
08/24/2011	EP2358756A1 High affinity human antibodies to pcsk9
08/24/2011	EP2358755A1 c-MET ANTIBODIES
08/24/2011	EP2358754A1 Ligands that bind il-13
08/24/2011	EP2358753A1 Myostatin binding proteins
08/24/2011	EP2358752A1 Compositions and methods for diagnosing and treating cancer and neurodegenerative diseases related to beclin-1
08/24/2011	EP2358394A1 Method and formulation for reducing aggregation of a macromolecule under physiological conditions

1 ... 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 ... 1494